| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/17/2006 | CA2639880A1 Anti-diabetic or anti-hypertensive dietary supplement |
| 08/17/2006 | CA2599036A1 Replication-deficient rna viruses as vaccines |
| 08/17/2006 | CA2597754A1 Methods and uses of antibodies in the purification of interferon |
| 08/17/2006 | CA2597751A1 New detoxification method |
| 08/17/2006 | CA2597649A1 Gip analog and hybrid polypeptides with selectable properties |
| 08/17/2006 | CA2597499A1 Fermentive vitamin c production |
| 08/17/2006 | CA2597462A1 Novel microbial enzymes and their use |
| 08/17/2006 | CA2597346A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | CA2597065A1 Compositions and methods related to soluble g-protein coupled receptors(sgpcrs) |
| 08/17/2006 | CA2596390A1 Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 08/17/2006 | CA2595495A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/17/2006 | CA2594405A1 Biomarkers and uses thereof |
| 08/16/2006 | EP1691197A2 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 08/16/2006 | EP1690949A1 Variant of HNF-1alpha gene having a single nucleotide polymorphism and variant of protein encoded by the same |
| 08/16/2006 | EP1690941A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 08/16/2006 | EP1690940A1 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 08/16/2006 | EP1690939A2 Novel G protein-coupled receptor proteins |
| 08/16/2006 | EP1690936A1 Method of enhancing hematopoiesis-supporting ability of immortalized human bone marrow stroma cell by transferring indian hedgehog gene |
| 08/16/2006 | EP1690935A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690934A2 Generation of xenogeneic antibodies |
| 08/16/2006 | EP1690933A1 hERG CHANNEL-EXPRESSING CELL |
| 08/16/2006 | EP1690932A1 Bone and/or joint disease-associated gene |
| 08/16/2006 | EP1690927A1 Natural killer cell lines and methods of use |
| 08/16/2006 | EP1690874A2 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 08/16/2006 | EP1690873A2 Composition and methods for the diagnosis of tumours |
| 08/16/2006 | EP1690872A2 Composition and methods for the diagnosis of tumours |
| 08/16/2006 | EP1690871A2 Xrec2 DNAs and polypeptides |
| 08/16/2006 | EP1690870A1 Marker peptide for alzheimer's disease |
| 08/16/2006 | EP1690868A1 Modification of virus tropism and host range by viral genome shuffling |
| 08/16/2006 | EP1690548A2 Cell cycle progression proteins |
| 08/16/2006 | EP1690547A1 Prevention and treatment of amyloidogenic disease |
| 08/16/2006 | EP1689886A1 Molecular marker associated with cmv resistance and use thereof |
| 08/16/2006 | EP1689882A2 Radioactive multiplexing analytical methods |
| 08/16/2006 | EP1689877A1 Fusion proteins and methods of cleavage of such proteins |
| 08/16/2006 | EP1689873A2 Lactic acid producing yeast |
| 08/16/2006 | EP1689872A1 Promoters for expression in modified vaccinia virus ankara |
| 08/16/2006 | EP1689868A1 Expression system for the b subunit of cholera toxin |
| 08/16/2006 | EP1689867A1 Immunization against chlamydia infection |
| 08/16/2006 | EP1689866A2 Msp-3-like family of genes |
| 08/16/2006 | EP1689865A2 A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto |
| 08/16/2006 | EP1689862A2 Tomatoes having reduced deoxyhypusine synthase activity caused by non-transgenic alterations in a deoxyhypusine synthase gene |
| 08/16/2006 | EP1689851A2 Modified polypeptides with therapeutic activity and methods of use |
| 08/16/2006 | EP1689849A2 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 08/16/2006 | EP1689783A2 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/16/2006 | EP1689778A1 Rgd targeting moiety its porduction and use |
| 08/16/2006 | EP1689777A1 Process for the purification of il-18 binding protein |
| 08/16/2006 | EP1689776A2 Equine p-selectin glycoprotein ligand-1 and uses thereof |
| 08/16/2006 | EP1689775A1 Gag binding proteins |
| 08/16/2006 | EP1689774A1 Sperm protective polypeptides and uses thereof |
| 08/16/2006 | EP1689773A2 Insulin releasing peptides |
| 08/16/2006 | EP1689772A2 Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease |
| 08/16/2006 | EP1689766A1 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 08/16/2006 | EP1689448A2 Improved method for preparing conjugates of proteins and chelating agents |
| 08/16/2006 | EP1689447A2 Gene transfer for regulating smooth muscle tone |
| 08/16/2006 | EP1689441A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 08/16/2006 | EP1689432A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 08/16/2006 | EP1689421A1 Selective neuropeptide y2 receptor agonists |
| 08/16/2006 | EP1689355A1 Selective inhibitors of nuclear factor-kb activation and uses thereof |
| 08/16/2006 | EP1689347A2 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 08/16/2006 | EP1623222A4 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 08/16/2006 | EP1546201A4 Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3. |
| 08/16/2006 | EP1543031B1 Monomeric insulin |
| 08/16/2006 | EP1509241B1 Novel uses of cephaibols |
| 08/16/2006 | EP1399476B1 Use of soluble cytokeratine-1-fragments in diagnostics |
| 08/16/2006 | EP1363930B1 A method for generating genetically altered antigens |
| 08/16/2006 | EP1297013B1 Use of taci as an anti-tumor agent |
| 08/16/2006 | EP1276853B1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 08/16/2006 | EP1268545B1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 08/16/2006 | EP1268530B1 Hepatitis b core antigen fusion proteins |
| 08/16/2006 | EP1252192B1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2006 | EP1220908B1 Isolated peptides which bind to mhc class ii molecules, and uses thereof |
| 08/16/2006 | EP1186301B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 08/16/2006 | EP1117682B1 Chi-Conotoxin Peptides as INhibitors of Neuronal Amine Transporters |
| 08/16/2006 | EP1115876B1 Receptor based antagonists and methods of making and using |
| 08/16/2006 | EP1084143B1 Purification process for production of mannan-binding lectin and an mbl medicinal product |
| 08/16/2006 | EP1064369B1 Nucleic acid binding proteins |
| 08/16/2006 | EP1064309B1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1053324B1 Novel cystine knot protein and materials and methods for making it |
| 08/16/2006 | EP0972037B1 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 08/16/2006 | EP0871749B1 Oil body proteins as carriers of high value proteins |
| 08/16/2006 | EP0827509B1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 08/16/2006 | EP0809655B1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
| 08/16/2006 | EP0784690B1 Complementary adenoviral vector systems and cell lines |
| 08/16/2006 | EP0314705B2 A novel family of primate hematopoietic growth factors |
| 08/16/2006 | CN1820080A Product quality enhancement in mammalian cell culture processes for protein production |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820075A Hepatitis B surface antigen blending gene and protein for carboxyl terminal containing precursor 32 immune decision cluster |
| 08/16/2006 | CN1820025A Fluorescein-labelled peptides |
| 08/16/2006 | CN1820024A Novel poly(ethylene glycol) modified compounds and uses thereof |
| 08/16/2006 | CN1820023A Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 08/16/2006 | CN1820022A Hepatitis c virus NS5B polymerase inhibitor binding pocket |
| 08/16/2006 | CN1820021A Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (SARS) |
| 08/16/2006 | CN1820020A SARS-coronavirus virus-like particles and methods of use |
| 08/16/2006 | CN1820019A Antimicrobial polypeptides |
| 08/16/2006 | CN1820018A Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 08/16/2006 | CN1819839A Immune-adjusting compound and relating method thereof |
| 08/16/2006 | CN1818066A Food-poisoning fungus concatenated fusion mycinamicin and use thereof |
| 08/16/2006 | CN1818065A Cotton GhZFP1 gene sequence, its clone and use |
| 08/16/2006 | CN1818064A Cotton metallothionein gene GhMT1 sequence, its clone and use |